Ablynx Achieves Third Milestone In Drug Discovery And Development Collaboration with Novartis AG
11/18/2009 10:20:10 AM
More...
|
Ablynx Provides Business Update For The Third Quarter 2009
11/10/2009 11:03:27 AM
More...
|
Ablynx Wins Award For 'Most Successful Early Phase Trial'
10/23/2009 11:01:04 AM
More...
|
Ablynx Provides An R&D Update And Announces Recent Technology Advances
10/19/2009 12:09:20 PM
More...
|
Ablynx And Domantis Limited Settle Their Dispute And Stop The Arbitration Process
10/12/2009 10:25:42 AM
More...
|
Ablynx Receives A Second Milestone Payment From Nanobody(R) Discovery And Development Alliance
10/5/2009 10:35:41 AM
More...
|
Ablynx Receives Milestone Payment As Part Of Its Strategic Alliance With Boehringer Ingelheim GmbH
10/1/2009 9:51:15 AM
More...
|
Wyeth Pharmaceuticals (New Jersey) (WYE) Initiates Phase II And Pays Ablynx Another Milestone of $4 Million In The Tnf-Alpha Nanobody(R) Collaboration
9/30/2009 10:24:26 AM
More...
|
Ablynx Announces Webcast Of Its Presentation At The UBS Global Life Sciences Conference In New York
9/15/2009 11:38:22 AM
More...
|
Ablynx Initiates Phase II Clinical Trial For Alx-0081
9/1/2009 10:37:05 AM
More...
|
|